BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31445888)

  • 1. Design of an immunohistochemistry biomarker panel for diagnosis of pancreatic adenocarcinoma.
    Burnett AS; Quinn PL; Ajibade DV; Peters SR; Ahlawat SK; Mahmoud OM; Chokshi RJ
    Pancreatology; 2019 Sep; 19(6):842-849. PubMed ID: 31445888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100P, von Hippel-Lindau gene product, and IMP3 serve as a useful immunohistochemical panel in the diagnosis of adenocarcinoma on endoscopic bile duct biopsy.
    Levy M; Lin F; Xu H; Dhall D; Spaulding BO; Wang HL
    Hum Pathol; 2010 Sep; 41(9):1210-9. PubMed ID: 20382408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of IMP3 and mesothelin in differentiating pancreatic ductal adenocarcinoma from chronic pancreatitis.
    Ibrahim DA; Abouhashem NS
    Pathol Res Pract; 2016 Apr; 212(4):288-93. PubMed ID: 26874572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of immunohistochemical IMP3 expression in core needle biopsies of pancreatic ductal adenocarcinoma.
    Wachter DL; Schlabrakowski A; Hoegel J; Kristiansen G; Hartmann A; Riener MO
    Am J Surg Pathol; 2011 Jun; 35(6):873-7. PubMed ID: 21566520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of pVHL, maspin, IMP3, S100P and Ki67 in the distinction of autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
    Hedegaard Jensen G; Mortensen MB; Klöppel G; Nielsen MFB; Nielsen O; Detlefsen S
    Pathol Res Pract; 2020 May; 216(5):152925. PubMed ID: 32273198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of IMP3, S100P, and pVHL immunopanel to aid in the interpretation of bile duct biopsies with atypical histology or suspicious for malignancy.
    Schmidt MT; Himmelfarb EA; Shafi H; Lin F; Xu H; Wang HL
    Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):478-87. PubMed ID: 22495381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of S100P and IMP3 in the cytologic diagnosis of pancreatic adenocarcinoma.
    Ezzat NE; Tahoun NS; Ismail YM
    J Egypt Natl Canc Inst; 2016 Dec; 28(4):229-234. PubMed ID: 27839709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Immunohistochemistry in Suspected Pancreatic Ductal Adenocarcinoma: A Prospective Study on Fine Needle Aspiration Biopsies.
    Valentini AM; Savino MT; Donghia R; Schena N; Arborea G
    Pancreas; 2022 Nov-Dec 01; 51(10):1372-1375. PubMed ID: 37099781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical staining for S100P, SMAD4, and IMP3 on cell block preparations is sensitive and highly specific for pancreatic ductal adenocarcinoma.
    Sweeney J; Rao R; Margolskee E; Goyal A; Heymann JJ; Siddiqui MT
    J Am Soc Cytopathol; 2018; 7(6):318-323. PubMed ID: 31043302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reevaluation and identification of the best immunohistochemical panel (pVHL, Maspin, S100P, IMP-3) for ductal adenocarcinoma of the pancreas.
    Liu H; Shi J; Anandan V; Wang HL; Diehl D; Blansfield J; Gerhard G; Lin F
    Arch Pathol Lab Med; 2012 Jun; 136(6):601-9. PubMed ID: 22646265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100P and XIAP expression in pancreatic ductal adenocarcinoma: potential novel biomarkers as a diagnostic adjunct to fine needle aspiration cytology.
    Kosarac O; Takei H; Zhai QJ; Schwartz MR; Mody DR
    Acta Cytol; 2011; 55(2):142-8. PubMed ID: 21325798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Value of S100p, IMP3, Maspin, and pVHL in the Differantial Diagnosis of Pancreatic Ductal Adenocarcinoma and Normal/chronic Pancreatitis in Fine Needle Aspiration Biopsy.
    Aksoy-Altinboga A; Baglan T; Umudum H; Ceyhan K
    J Cytol; 2018; 35(4):247-251. PubMed ID: 30498299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Annexin A10 optimally differentiates between intrahepatic cholangiocarcinoma and hepatic metastases of pancreatic ductal adenocarcinoma: a comparative study of immunohistochemical markers and panels.
    Kälsch J; Padden J; Bertram S; Pott LL; Reis H; Westerwick D; Schaefer CM; Sowa JP; Möllmann D; Fingas C; Dechȇne A; Sitek B; Eisenacher M; Canbay A; Ahrens M; Baba HA
    Virchows Arch; 2017 May; 470(5):537-543. PubMed ID: 28357490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic utility of S100P and von Hippel-Lindau gene product (pVHL) in pancreatic adenocarcinoma-with implication of their roles in early tumorigenesis.
    Lin F; Shi J; Liu H; Hull ME; Dupree W; Prichard JW; Brown RE; Zhang J; Wang HL; Schuerch C
    Am J Surg Pathol; 2008 Jan; 32(1):78-91. PubMed ID: 18162774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of maspin in distinguishing adenocarcinoma from benign biliary epithelium on endoscopic bile duct biopsy.
    Chen L; Huang K; Himmelfarb EA; Zhai J; Lai JP; Lin F; Wang HL
    Hum Pathol; 2015 Nov; 46(11):1647-54. PubMed ID: 26362203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semiquantitative immunohistochemistry for mucin (MUC1, MUC2, MUC3, MUC4, MUC5AC, and MUC6) profiling of pancreatic ductal cell adenocarcinoma improves diagnostic and prognostic performance.
    Sierzega M; Młynarski D; Tomaszewska R; Kulig J
    Histopathology; 2016 Oct; 69(4):582-91. PubMed ID: 27165582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical distinction between intrahepatic cholangiocarcinoma and pancreatic ductal adenocarcinoma.
    Lok T; Chen L; Lin F; Wang HL
    Hum Pathol; 2014 Feb; 45(2):394-400. PubMed ID: 24439226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and diagnostic value of HE4 in pancreatic adenocarcinoma.
    Huang T; Jiang SW; Qin L; Senkowski C; Lyle C; Terry K; Brower S; Chen H; Glasgow W; Wei Y; Li J
    Int J Mol Sci; 2015 Jan; 16(2):2956-70. PubMed ID: 25642754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical Antibody Panel for the Differential Diagnosis of Pancreatic Ductal Carcinoma From Gastrointestinal Contamination and Benign Pancreatic Duct Epithelium in Endoscopic Ultrasound-Guided Fine-Needle Aspiration.
    Furuhata A; Minamiguchi S; Shirahase H; Kodama Y; Adachi S; Sakurai T; Haga H
    Pancreas; 2017 Apr; 46(4):531-538. PubMed ID: 28099249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of IMP3 in identification of carcinoma in fine needle aspiration biopsies of pancreas.
    Yantiss RK; Cosar E; Fischer AH
    Acta Cytol; 2008; 52(2):133-8. PubMed ID: 18499984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.